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Objectives: The amyloid imaging PET tracer [18F]ﬂutemetamol was recently approved by regulatory authorities in
the US and EU for estimation of β-amyloid neuritic plaque density in cognitively impaired patients. While the
clinical assessment in line with the label is a qualitative visual assessment of 20 min summation images, the
aim of this workwas to assess the performance of various parametric analysis methods and standardized uptake
value ratio (SUVR), in comparison with arterial input based compartment modeling.
Methods: The cerebellar cortex was used as reference region in the generation of parametric images of binding
potential (BPND) using multilinear reference tissue methods (MRTMo, MRTM, MRTM2), basis function
implementations of the simpliﬁed reference tissue model (here called RPM) and the two-parameter version of
SRTM (here called RPM2) and reference region based Logan graphical analysis. Regionally averaged values of
parametric results were compared with the BPND of corresponding regions from arterial input compartment
modeling. Dynamic PET datawere also pre-ﬁltered using a 3DGaussian smoothing of 5mmFWHMand the effect
of the ﬁltering on the correlationwas investigated. In addition, the use of SUVR imageswas evaluated. The accuracy of
several kineticmodelswerealsoassessed through simulationsof time–activity curvesbasedonclinical data for lowand
high binding adding different levels of statistical noise representing regions and individual voxels.
Results: The highest correlation was observed for pre-ﬁltered reference Logan, with correction for individual reference
region efﬂux rate constant k2′ (R2=0.98), or using a cohortmean k2′ (R2=0.97). Pre-processingﬁlteredMRTM2, un-
ﬁltered SUVR over the scanningwindow 70–90min and unﬁltered RPM also demonstrated high correlations with ar-
terial input compartmentmodeling (MRTM2 R2=0.97, RPMR2=0.96 and SUVR R2=0.95) Poorest agreementwas
seen with MRTMwithout pre-ﬁltering (R2 = 0.68).
Conclusions: Parametric imaging allows for quantiﬁcation without introducing bias due to selection of anatomical re-
gions, and thus enables objective statistical voxel-based comparisons of tracer binding. Several parametric modeling
approaches perform well, especially after Gaussian pre-ﬁltering of the dynamic data. However, the semi-quantitative
use of SUVR between 70 and 90 min has comparable agreement with full kinetic modeling, thus supporting its use
as a simpliﬁed method for quantitative assessment of tracer uptake.© 2015 Elsevier Inc. All rights reserved.Introduction
Alzheimer's Disease (AD) is typically described as a condition where
presence of progressive dementia is accompanied by neuropathological
changes that include neuroﬁbrillary tangles (Braak and Braak, 1991)
and β-amyloid plaques (Thal et al., 2002).With a steadily increasing el-
derly population, the prevalence of dementia and in particular AD isiska sjukhuset, 751 85 Uppsala,
rling).increasing andmore speciﬁc techniques to assist in the accurate diagno-
sis are demanded.
Positron emission tomography (PET) is a non-invasive molecu-
lar imaging method for diagnosis and monitoring of treatment effects,
where it visualizes physiological processes in vivo. Due to its high spa-
tial and temporal resolution, it is well suited for neurological applica-
tions including imaging of β-amyloid, initially introduced by Klunk
et al. (2004) using the 11C-labelled tracer Pittsburgh Compound B
([11C]PiB) (Klunk et al., 2004). The β-amyloid imaging PET tracer
[18F]ﬂutemetamol, an 18F-labelled analogue of [11C]PiB, was recently
approved by the US Food and Drug Administration and the
European Medicines Agency for estimation of β-amyloid neuritic
185K. Heurling et al. / NeuroImage 121 (2015) 184–192plaque density in cognitively impaired patients under the trademark
name Vizamyl™ (GE Healthcare Ltd, UK).
Data included in this study are part of a previously performed Phase I
study of [18F]ﬂutemetamol sponsored byGEHealthcare Ltd. The original
study included eight subjects with probable AD (pAD) and 14 healthy
volunteers (HV), in total 22 subjects, of which six HV subjects under-
went whole body scanning for investigation of biodistribution and do-
simetry (Koole et al., 2009). Six subjects underwent dynamic brain
PET between time of injection and 250 min post injection divided into
three scanning windows, including arterial blood sampling. Ten sub-
jects underwent a simpliﬁed scanning procedure, following the interim
analysis of the six dynamically scanned subjects, over a limited time
window of 80–170 min post injection of [18F]ﬂutemetamol with no
blood sampling (Nelissen et al., 2009). Based on the six dynamically
scanned subjects, it was concluded that the volume of interest (VOI)
based tracer kinetics were best described by a reversible 2-tissue
compartment (2-TC) model (Nelissen et al., 2009). It was also shown
that the tracer kinetics in the proposed reference region, the cere-
bellar cortex—a region known to be largely devoid of β-amyloid
accumulation—could be described using a 1-tissue compartment
model, but slightly better by a 2-TC model, indicating a small contribu-
tion of binding with different kinetic properties than the inﬂux/efﬂux
of the tracer to the uptake. The use of cerebellar cortex as a reference re-
gion was validated as having high correlation with plasma input based
quantiﬁcation, along with the use of standardized uptake value ratio
(SUVR) over a shorter time window. In the ten subjects scanned
between 80 and 170 min, the optimal time for SUVR estimation was
investigated. Scanning length and scanning start time was determined
to have little effect on the discriminatory abilities of [18F]ﬂutemetamol
beyond 80 min post injection (Nelissen et al., 2009). For clinical use
the recommended scanning window is to start acquisition at approxi-
mately 90 min post injection and scan over 20 min.
Following this, the efﬁcacy of blinded visual assessments of
[18F]ﬂutemetamol as well as of SUVR for discrimination of pAD subjects
fromHVwasdetermined in a Phase II study (Vandenberghe et al., 2010)
using the clinical diagnosis as standard of truth. Forty subjects (pAD and
amnestic mild cognitive impairment (aMCI)) also received a [11C]PiB
scan and the correlation of SUVR between the two tracers was found
to be excellent in the grey matter cortical regions, but less so in white
matter rich regions of the brain. There was a total agreement in the vi-
sual assessment of the two tracers. In a cohort of end-of-life patients,
the sensitivity and speciﬁcity of visual assessments of [18F]ﬂutemetamol
images compared to post mortem diagnosis were determined (Curtis
et al., 2015). The sensitivity ranged from 81% to 93% (median 88%)
among ﬁve blinded readers and the median speciﬁcity was 88%.
To date, [18F]ﬂutemetamol PET scans have mainly been evaluated
using visual assessment, or by regional semi-quantitative analysis of
the tracer uptake by the means of SUVR using cerebellar cortex or
pons as a reference region. Regional quantitative analysis removes the
detailed spatial information of the PET images. The loss of such detail
can however be circumvented by applying the kinetic models on the
ﬁnest spatial level i.e. at the voxel level. This enables voxel-based statis-
tical comparisons without any bias from pre-deﬁnition of VOIs to test
the spatial difference in parameter distribution between groups or in a
longitudinal study setting. In addition to the mere quantitative beneﬁt
of using parametric imaging, the application of these images in the
context of visual assessment has recently been investigated for
[11C]PiB images demonstrating a higher interreader and intermeth-
od agreement for BPND images than SUVR (Zwan et al., 2014). As of
today, there have been no reports of the application of parametric imag-
ing to [18F]ﬂutemetamol PET scanning.
The objective of the current study was to investigate the perfor-
mance of various methods for creating [18F]ﬂutemetamol parametric
images representing the speciﬁc uptake of the tracer, using clinical
data as well as testing the applicability of different kinetic models
through simulation studies.Methods
Participants
This post hoc study was limited to only include the image data from
the ﬁrst scanning window in the six subjects with dynamic data of the
Phase I subjects, as the remaining subjects did not have data necessary
for the analyses performed. Three were healthy volunteers (HV), one
male and two females (mean age, range: 62.3, 56–71 years) with a
Mini-Mental State Examination (MMSE) scoring above 27 of 30 and a
Clinical Dementia Rating of 0. Three subjects had a diagnosis of early-
stage clinically probable Alzheimer's Disease, all were males (mean
age, range: 62, 55–68 years). The pAD subjects had to fulﬁl the criteria
of the National Institute of Neurological and Communicative Disorders
and Stroke and of the Alzheimer's Disease and RelatedDisorders Associ-
ation for clinically probable AD aswell as theDSM-IV criteria for demen-
tia of Alzheimer's type. The inclusion criteria included a MMSE score
between 18 and 26 and a Clinical Dementia Rating between 0.5 and 2.
At the time of the PET scanning, all pAD patients were receiving regular
treatment with a cholinesterase inhibitor and selective serotonin-
reuptake inhibitors, and one was receiving quetiapine. For more de-
tailed information on the neuropsychology testing, see Nelissen et al.,
2009. All participants provided their written informed consent in accor-
dance with the Declaration of Helsinki and the study protocol was ap-
proved by the Ethical Committee of the University Hospitals Leuven.
Data acquisition
As part of the screening, each subject underwent anMRI scanwithin
30 days before the subject's PET scan. TheMRIwas performed on a 1.5 T
Intera scanner (Philips, Guildford, Surrey, UK), and the protocol includ-
ed a high-resolution T1-weighted image. The scan was used to exclude
participants with structural abnormalities and for co-registration and
segmentation during the PET data processing. The PET studieswere per-
formed on a HiRez Biograph 16 PET/CT (Siemens, Knoxville, TN, USA) in
3D listmode, with the acquisition starting at the time of intravenous ad-
ministration of Flutemetamol (F 18) Injection in the antecubital vein
with a target dose of 185MBq. The subject's headwas ﬁxed using a vac-
uumpillow to avoid excessive headmovement. At the beginning of each
PET scan, a low dose CT scan (80 kV tube potential, 11 mAs) was con-
ducted for attenuation correction. The data were reconstructed into 25
frames over 90 min (4 × 30, 6 × 60, 4 × 180, 8 × 300 s) using Fourier
re-binning and 2D ordered subsets expectation maximization (81
axial slices, 5 iterations and 8 subsets, 128 × 128 matrix, 2.5× zoom,
2.13 × 2.13 × 2 mm pixels, 2 mm slice separation and a Gaussian ﬁlter
with a FWHMof 5mm, no smoothing in the axial direction). The recon-
struction included all the appropriate corrections such as for attenua-
tion, randoms and scatter.
Arterial blood samples were collected every 10 s during the ﬁrst
minute, every 15 s up till 3 min after injection and at 4, 8, 15, 30, 45,
60 and 90 min for radioactivity measurements in whole blood and
plasma. In addition arterial samples were collected at 2, 5, 20 and 60,
180 and 240 min for determination of percentage of radioactive parent
compound and metabolites. Based on this, a metabolite-corrected plas-
ma input curve was created and used for kinetic modeling of the tracer
uptake.
Image processing
The dynamic PET data were realigned frame-by-frame to correct for
motion (Andersson, 1995) during the scan and each MRI was realigned
to a plane parallel to the line connecting the anterior and posterior
commissure using VOIager4 (GE Healthcare, Uppsala, Sweden). The
PET images were co-registered to the reformatted MRI by means of a
summation image of frames 2–10 (30 s–8 min p.i.) using Statistical
Parametric Mapping (SPM5; Wellcome Trust Center for Neuroimaging,
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probabilistic VOI template in the PVElab software (Svarer et al., 2005).
The VOIs were then applied to the dynamic PET data generating mean
time–activity curves (TACs) for 16 grey matter regions averaged over
the left and right hemispheres (superior frontal cortex, medial inferior
frontal cortex, orbitofrontal cortex, dorsolateral prefrontal cortex, ven-
trolateral prefrontal cortex, superior temporal cortex, medial inferior
temporal cortex, insula, parietal cortex, thalamus, sensorymotor cortex,
occipital cortex, putamen, caudate, anterior cingulate cortex and poste-
rior cingulate cortex).
VOI based kinetic analysis
A 2-tissue compartment (2-TC) model (Gunn et al., 2001) was used
for estimation of the tracer binding through non-linear least squares
curve-ﬁtting, using the metabolite-corrected plasma input function.
The appropriateness of this model in describing the tracer uptake had
previously been demonstrated (Nelissen et al., 2009). The model
assumes that the equilibrium between free tracer and non-speciﬁc
binding is too fast to separate them, and they are thus combined into
one compartment of non-displaceable binding. The binding potential
(BPND) for each region was estimated both directly and indirectly
as the ratio of volumes of distribution VT in each region relative to cere-
bellar grey cortex as reference region, resulting in the distribution vol-
ume ratio DVR-1 (Lammertsma and Hume, 1996). The compartment
model-based binding estimates were considered the gold standard
and the other models were compared against them. Clearance rates
estimated from 2-TCwere used to conﬁrm the validity of the basis func-
tions used in the parametric models. Region-based analysis was also
performed on the TACs using the simpliﬁed reference tissue model
(SRTM, (Lammertsma and Hume, 1996)). Use of the graphical Logan
analysis methods was already previously presented on this data as
being successful in quantifying the uptake of [18F]ﬂutemetamol
(Nelissen et al., 2009).
Parametric images
Parametric maps were generated using an in-house-developed
MATLAB based implementation of the following models: multilinear
reference tissue models MRTMo, MRTM and MRTM2 (Ichise et al.,
1996, 2003), the voxel-based basis function implementations of SRTM
(Gunn et al., 1997; Lammertsma and Hume, 1996) and SRTM2 (Wu
and Carson, 2002), commonly and hereafter in this paper called recep-
tor parametric mapping (RPM and RPM2), as well as voxel-based refer-
ence Logan (Logan et al., 1996). Cerebellar grey matter was used as
reference region in all models. A voxel-based representation of SUVR
was also created for the summation image over 70–90 min using cere-
bellar grey matter as reference region, chosen because it was the time
window closest to the recommended time window for clinical use. For
RPM and RPM2, 50 basis functions with logarithmically spaced expo-
nential clearance rates ranging between 0.012 and 0.6 min−1 were
used. These boundaries were compared to the clearance rates estimated
during the region-based 2-TC analysis of all subjects. The number of
parameters estimated in RPM2 is reduced by ﬁxing the reference
tissue efﬂux rate constant (k2′) based on RPM estimates in order de-
crease the introduction of quantiﬁcation errors due to statistical noise.
The multilinear reference tissue models (MRTMo, MRTM and MRTM2)
estimate the tracer binding by means of multilinear regression. Similar
to the RPM2, the number of estimated parameters is reduced for
MRTM2, by using a ﬁxed value for k2′ based on the average k2′ from
the MRTMmodel.
The reference Logan model provides parametric maps of DVR, using
a linearization of the uptake in each voxel and the reference region over
the dynamic window speciﬁed, here 50–90 min. As the ratio of target
to reference region uptake could not be assumed to be constant during
the time window studied, the k2′ for the cerebellar cortex VOI wasdetermined graphically using plasma input Logan (Logan et al., 1996).
Parametric images were created with and without inclusion of the k2′
to assess the impact of this correction, and k2′ was either individually
determined or based on the cohort mean. Since some parametric
methods, especially graphical analyses, are sensitive to noise (Slifstein
and Laruelle, 2000), the dynamic reconstructed data were smoothed
by applying an isotropic Gaussian ﬁlter of 5 mm FWHM (Klumpers
et al., 2012) before estimation of parametric images and compared to
no additional smoothing. SUVR images were excluded from this analy-
sis, as they do not suffer from noise impact on model ﬁtting in the
same way as the parametric models.
Evaluation of parametric methods
The greymatter masked VOIs, generated using PVElab, were applied
to all parametric images for estimation of regional average values of the
voxels in each VOI, for either BPND, DVR-1 or SUVR-1. The square of the
correlation coefﬁcient (R2) and slope and intercept for the linear regres-
sion of the 2-TC based BPND and the parametric image estimatewere es-
timated for eachmodel. The regional estimate of orbitofrontal cortex for
each subject and each model was used to visualize the discriminatory
ability of the models, however due to the limited sample size no formal
statistical analysis was made.
Simulations
The validity of different kinetic models in the estimation of
[18F]ﬂutemetamol was tested through simulations, where TACs were
generated for target and reference regions representing typical
[18F]ﬂutemetamol kinetics using a plasma input curve and the plasma
input reversible 2-TC model (Gunn et al., 2001). Parameter values
were based on the clinical data. A noise level of 2% or 10%, correspond-
ing to noise levels present in VOI TACs or single voxel TACs, was added
to the simulated target signal, whereas a noise level of 2% was added to
the simulated reference region TAC. The models tested were the 2-TC
model estimation of BPND and DVR-1, SRTM, reference Logan and
RPM. One hundred TACs with added noise were generated, and the
evaluation was based on the bias and coefﬁcient of variation (CoV) of
both BPND and DVR-1. In addition to this, SUVR was investigated for
the time interval 70–90 min. To test the correlation between the true
BPND or DVR-1 and the different simpliﬁcations, 100 different BPND
and DVR-1 levels randomly chosen between 0.38 and 1.14 were simu-
lated and the square of correlation coefﬁcient (R2) and slope between
the different binding estimates were computed.
Results
Plasma input functions and time activity curves
Examples of TACs for orbitofrontal cortex, a regionwhere β-amyloid
accumulation is often observed, and cerebellar cortex, known to have
none to very little accumulation of β-amyloid, are shown for a represen-
tative HV subject and pAD in Fig. 1a and b, together with the average
metabolite-corrected plasma input function in 1c. In Fig. 1d the mean
and standard deviation across all subjects for the fraction of remaining
unmetabolized [18F]ﬂutemetamol at each time point are shown.
VOI based kinetic analysis
The kinetics of [18F]ﬂutemetamol were well described by the 2-TC
model. However, the indirect estimates of BPND as DVR-1, through esti-
mation of VT and using cerebellar cortex as a reference region proved
more robust than the direct estimations of BPND based on the variance.
While SRTM resulted in the best ﬁts to experimental data according to
the Akaike criterion, the correlation with the 2-TC model estimates
was poor. The estimated kinetic parameters from the direct 2-TC
Fig. 1. Time activity curves for a representative a) HV subject and b) pAD subject in the orbitofrontal cortex and cerebellum, c) the mean metabolite corrected plasma input function and
whole blood activity concentration and d) the mean fraction of unmetabolized tracer at different time points and standard deviation of all 6 subjects.
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cortex, parietal cortex, anterior cingulate, posterior cingulate and tem-
poral cortex) for pAD and HV subjects are listed in Table 1. The estimat-
ed parameters were used as input for the simulation studies. Based on
the conclusion that the indirectly estimated BPND (i.e. DVR-1) values
were amore robust estimate, the performance of the parametricmodels
was assessed using that as gold standard.
Parametric images
The grey matter VOI averages from each parametric image were
compared to the 2-TC estimate of DVR-1. The cohort mean k2′ in cere-
bellar cortex, as determined graphically using region-based arterial
input Logan, was 0.049 ± 0.010 (range 0.036–0.074min−1), hence ref-
erence Logan parametric images were generated using 0.049 as k2′ for
the reference region, each subject's individually determined k2′ or none.
The deﬁnition of basis functions in the RPMmethods was compared
to the clearance rates estimated from the regional 2-TC, and conﬁrmedTable 1
Average estimated values (±SD) of kinetic parameters, as obtained by the 2-TC.
VT BPND K1
HV, Cerebellar cortex
(mean ± SD, n = 3)
4.57 ± 0.49 0.46 ± 0.03 0.28 ± 0.02
pAD, Cerebellar cortex
(mean ± SD, n = 3)
3.88 ± 0.57 0.55 ± 0.37 0.30 ± 0.23
HV, Global cortical
(mean ± SD, n = 3)
5.76 ± 0.72 0.87 ± 0.28 0.25 ± 0.03
pAD, Global cortical
(mean ± SD, n = 3)
5.86 ± 0.93 0.90 ± 0.26 0.23 ± 0.03that the clearance rates observedwere well within the deﬁned window
used for the basis functions (2-TC clearance rates: 0.033 to 0.13 min−1,
basis function deﬁnition clearance rates: 0.012 to 0.6 min−1).
R2, slope and intercept of the linear regression between the 2-TC
model estimates and corresponding based on each parametric method
for all subjects and all regions are listed in Table 2. The inclusion of k2′
in the generating of reference Loganparametric images had nomajor ef-
fect on slope and intercept, although the highest R2 was achievedwhen
including each subject's individual k2′, and decreased somewhat when
approximating the k2′with the cohort mean or ignoring k2′ altogether.
Pre-ﬁltering of the dynamic data using a 3D Gaussian ﬁlter of 5 mm
FWHM improved the correlation with 2-TC in all multilinear reference
models, aswell as in the reference Loganwhere k2′wasbased on the co-
hort mean. In the remaining two reference Logan models, the correla-
tion coefﬁcient was largely unaffected by the applied ﬁlter, while the
correlation of basis functionmethods RPMandRPM2decreased slightly.
The highest correlations between 2-TC and the parametric methods
were found for MRTM2 with pre-ﬁlter, reference Logan with individualk2 k3 k4 Vb
0.09 ± 0.01 0.02 ± 0.005 0.03 ± 0.01 0.06 ± 0.004
0.18 ± 0.02 0.05 ± 0.05 0.09 ± 0.03 0.05 ± 0.001
0.08 ± 0.004 0.02 ± 0.005 0.02 ± 0.003 0.06 ± 0.01
0.08 ± 0.01 0.02 ± 0.01 0.02 ± 0.002 0.050 ± 0.01
Table 2
Regression parameters (Pearson's correlation coefﬁcient R2, slope and intercept) of parametric image estimates with DVR-1 from arterial input 2-TC.
Unﬁltered Pre-ﬁltered
5 mm FWHM 3D Gaussian
Parametric outcome R2 Slope Intercept R2 Slope Intercept
MRTMo (BPND) 0.87 0.73 −0.07 0.89 0.76 −0.09
MRTM (BPND) 0.68 0.79 −0.04 0.84 0.99 −0.10
MRTM2 (BPND) 0.81 0.97 0.08 0.97 1.08 −0.01
Ref Logan with individual k2′ (DVR-1) 0.97 0.90 −0.03 0.98 0.89 −0.03
Ref Logan with cohort mean k2′ (DVR-1) 0.85 0.84 0.01 0.97 0.92 −0.04
Ref Logan without k2′ (DVR-1) 0.94 0.83 −0.05 0.94 0.82 −0.07
RPM (BPND) 0.95 1.08 −0.04 0.94 1.08 −0.06
RPM2 (BPND) 0.89 1.09 −0.10 0.86 1.05 −0.12
SUVR70–90 (SUVR-1) 0.96 1.22 0.04 – – –
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mean k2′ if pre-ﬁlter was applied, followed by RPM and SUVR without
pre-ﬁltering. Correlation plots of MRTM, RPM, reference Logan and
SUVR70–90-1 are shown in Fig. 2.
The parametric images of the different models from a subject with
pAD are shown in Fig. 3, selecting either the unﬁltered or pre-ﬁltered
version of each model that had the highest correlation to 2-TC quantiﬁ-
cation. The multilinear reference models and the basis function
methods had a similar visual appearance while the reference Logan
methods and the SUVR image looked alike. MRTM suffered from ex-
treme value artifacts in spite of the applied pre-ﬁlter, although this de-
creased through the application of a pre-processing ﬁlter. Examples of
the improvement in image quality of the multilinear reference models
can be seen in Fig. 4.
The estimated binding or uptake in orbitofrontal cortex was plotted
for all subjects to visualize the separation of the data for patient group inFig. 2. Scatter plots of estimates of uptake in VOIs of HV and pAD subjects (n= 6 total) with 2-T
DVR-1 and d) SUVR70–90-1.each model. All models demonstrate a good separation between pAD
andHVsubjects, but also identify oneof theHV subjects as having raised
[18F]ﬂutemetamol uptake. The estimated uptake in orbitofrontal cortex
of each subject for all models, with or without pre-processing ﬁlter ap-
plied as determined above, is shown in Fig. 5.
Simulations
Strong correlations were seen for RPM between the true values and
themodel estimates (R2=0.99)when noise corresponding to the noise
in VOI TACswas added. SUVR70–90-1 andDVR-1 based on both reference
Logan and 2-TC also showed good correlation (R2=0.97 for SUVR70–90-
1, R2=0.96 for reference Logan and R2=0.94 for 2-TC),whereas SRTM
performed poorly (R2 = 0.18) failing to ﬁnd an appropriate ﬁt of the
model to the data in approximately 50% of the simulations indicating
that SRTM is not appropriate for quantiﬁcation of [18F]ﬂutemetamolC DVR-1 versus a)MRTM BPND, b) reference Logan (with cohort mean k2′) DVR-1, c) RPM
Fig. 3. [18F]Flutemetamol parametric images of an axial plane through the middle of the brain from a typical pAD subject. Four different classes of parametric methods, and in total nine
different variants, were used. For reference Logan the voxel unit isDVR-1,with the samemaximum image intensity as BPND, and for SUVR70–90 the ratio of voxel radioactivity concentration
and cerebellar radioactivity concentration (SUVR-1).
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Logan: the Pearson correlation coefﬁcients, slopes and intercept of the
correlations and the bias and CoV of the simulated models are listed in
Table 3.
With a higher noise level added to the simulated TACs, reﬂecting the
noise of a voxel TAC, the correspondence was poorer for all models
demonstrating the main challenge with parametric imaging. However,
RPM showed the highest correlation (R2 = 0.83) again, followed by
SUVR70–90-1 (R2 = 0.76) and reference Logan (R2 = 0.64). The Pearson
correlation coefﬁcients, slopes, intercept, bias and CoV are listed in
Table 3. Graphs of the correlation for the 100 simulated BP values both
on VOI and voxel noise levels are shown in Fig. 6.Discussion
To date, there have been no records of the application and perfor-
mance of parametric image methods on any of the [18F]-labelled com-
pounds for amyloid imaging. However, both the technical and clinical
application of parametric imaging have been investigated for the 11C-
labelled compound [11C]PiB, demonstrating high accuracy and precision
of RPM2 andMRTM2parametricmethods (Yaqub et al., 2008) aswell as
higher interreader and intermethod agreement for BPND images (Zwan
et al., 2014) than SUVR images.
In this study the performance of eight different reference tissue based
parametric imaging methods and SUVR images for [18F]ﬂutemetamol
Fig. 4. Effect of pre-processing ﬁlter on multilinear reference tissue models. Top row showing MRTMo, MRTM and MRTM2 without any applied ﬁlter, bottom row showing the same
models but where dynamic PET data had been smoothed using a 3D Gaussian ﬁlter with 5 mm FWHM before the kinetic models were applied on voxel-level in the same pAD subject
as in Fig. 3.
Fig. 5. Nine methods of quantiﬁcation of [18F]ﬂutemetamol uptake in orbitofrontal cortex
in three AD subjects (circles) and three HV subjects (squares), showing the discriminatory
ability of each method. The leftmost series is the region based arterial input 2-TC quanti-
ﬁcation of DVR-1, shown as a reference. One of the HV subjects has elevated uptake, sim-
ilar to the level of the pAD subjects.
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arterial plasma input, as well as the impact of pre-processing ﬁltering
on the performance of the kinetic models. The theoretical performance
of different kinetic models using simulations was also investigated.
Several models performed well, demonstrating a high agreement
of the regional averages of the parametric images to the regional
based 2-tissue compartment (2-TC)model. Among the eight parametric
methods, three had correlation coefﬁcients R2 ≥ 0.9. After applied pre-
ﬁlter, ﬁve of the eight parametric methods had R2 ≥ 0.9. The methods
beneﬁtingmost of the appliedﬁlter was the linearmethods (multilinear
reference tissue models and reference Logan models), likely since these
methods are highly sensitive to the noise decreased by the Gaussian
5 mm FWHM ﬁlter. Pre-ﬁltered reference Logan corrected using
individual k2′ and pre-ﬁltered MRTM2 had the highest correlation
with 2-TC modeling of all investigated methods, while MRTM showed
the poorest agreement. SUVR over the scanning window 70–90 min
also showed a high agreement with compartmental modeling. Filter
type and width was chosen based on previously published ﬁndings
(Klumpers et al., 2012) and no optimization was done to investigate
whether a different ﬁlter size could further improve the correlations
with the 2-TC quantiﬁcation. While a higher FWHM may decrease
noise more, it may also induce higher partial volume effects.
Table 3
Accuracy and precision of simulations. R2, slope and intercept vs 2-TC.
Model Target noise
level
Reference
parameter
R2 Slope Intercept Bias CoV
2-TC BPND 2% 2-TC BPND 0.94 0.98 0.03 1.5 6.1
2-TC DVR-1 2% 2-TC DVR-1 0.91 0.97 0.02 3.3 12.1
SRTM BPND 2% 2-TC DVR-1 0.18 −41.40 29.61 N/A N/A
RPM BPND 2% 2-TC DVR-1 0.99 1.12 −0.08 −4.6 4.6
Ref Logan DVR-1 2% 2-TC DVR-1 0.96 0.89 −0.03 −17.4 8.1
SUVR70–90-1 2% 2-TC DVR-1 0.97 1.13 −0.02 11.7 6.6
2-TC BPND 10% 2-TC BPND 0.01 −6.77 10.52 N/A N/A
2-TC DVR-1 10% 2-TC DVR-1 0.005 −6.34 7.13 N/A N/A
SRTM BPND 10% 2-TC DVR-1 0.00 0.43 15.96 N/A N/A
RPM BPND 10% 2-TC DVR-1 0.83 1.08 −0.11 −12.5 22.4
Ref Logan DVR-1 10% 2-TC DVR-1 0.64 0.77 −0.04 −28.2 38.0
SUVR70–90-1 10% 2-TC DVR-1 0.76 1.09 0.01 15.7 20.5
191K. Heurling et al. / NeuroImage 121 (2015) 184–192Reference Logan parametric images were created both with
and without correction for k2′, based either on a cohort mean or deter-
mined individually for each subject using arterial input Logan. The
inclusion of this correction factor had no major impact on the slope or
intercept of the correlation with the 2-TC model, but the correlation
coefﬁcient was highest when including the individually determined
k2′ and lowest when including the cohort mean. However, applying a
pre-processing ﬁlter to the dynamic data before quantiﬁcation in-
creased the correlation between 2-TC modeling and the k2′-corrected
reference Logan models substantially, resulting in the highest observed
correlation coefﬁcient among all models for reference Logan corrected
using the individually determined k2′. It should be noted however,
that while the inclusion of a correction for k2′ increases the model cor-
relation with 2-TC estimates, this requires arterial blood sampling forFig. 6. Model estimation correlation of a range of simulated endpoints for a) 2-TC, b) RPM,
representing VOI analysis and 10% (open circles) representing voxel based analysis. Note that
the low R2, are not shown.determination of the individual values or the use of an approximation
of a mean k2′. Reported here was a cohort mean of 0.049 min−1, but
this should be used with caution as it is based on a limited sample size
of only six subjects. In the light of this, it may be preferable to ignore
k2′ altogether when using reference Logan for [18F]ﬂutemetamol para-
metric images.
The discriminating abilities of the different parametric methods
were not directly investigated in this study due to the limited sample
size. However, we have graphically presented the uptake in an example
region, orbitofrontal cortex, quantiﬁed for each subject using all
methods. One of the healthy controls showed an elevated uptake,
most likely a case of prodromal β-amyloid accumulation, but the re-
maining two can be easily distinguished from the pAD subjects regard-
less of method.c) reference Logan and d) SUVR70–90-1 vs 2-TC DVR-1, for noise level 2% (ﬁlled circles)
the y-axis maximum in a) is set to 0.8 so extreme values for the 10% estimates, causing
192 K. Heurling et al. / NeuroImage 121 (2015) 184–192The simulation study showed that 2-TC estimated BPND has a high
accuracy, but a lower precision at the 2% noise level, representing the
noise in a VOI based analysis. While the 2-TC model can be sensitive
to noise in the time–activity data, this indicates that for the region-
based quantiﬁcation of [18F]ﬂutemetamol compartment modeling
performs well and thus is appropriate to use as gold standard for the
evaluation of the parametric methods. Of the parametric methods in-
cluded in the present work, RPM and SUVR70–90 had both high accuracy
and precision.
SRTM demonstrated both a very low precision and low accuracy,
due to the model failing to ﬁnd a good ﬁt to the simulated TACs in
about 50% of the simulations. Therefore, relevant estimates of bias and
CoV could not be achieved. A possible reason for the instability of
SRTM may be the relatively small speciﬁc binding component in the
[18F]ﬂutemetamol signal, aswell as the fact that neither target nor refer-
ence tissue TACs can be described by a single tissue compartmentmodel
(Nelissen et al., 2009), which is one of the prerequisites for SRTM. RPM,
a basis function implementation of SRTM, and RPM2 perform better
probably because these models put additional constraints on the possi-
ble parameter values.
When 10% noise was added to the TACs, which was approximated
to represent the noise level in a voxel-based parametric image analysis,
the 2-TC estimated BPND had frequent problemsﬁnding the correctﬁt of
the model to simulated data, so no estimates of accuracy and precision
could be estimated, which is an indication of the sensitivity to noise of
this model. Reference Logan and SUVR70–90-1 had higher accuracy but
a somewhat lower precision than RPM.
One challenging factor with quantiﬁcation of the [18F]ﬂutemetamol
signal is spill-over from white matter to grey matter regions. Since the
clearance of [18F]ﬂutemetamol from white matter is slower than from
grey matter, this may cause the appearance of spurious slow compart-
ments in grey matter regions. The basis function implementation of
SRTM2, RPM2, largely removes the signal from non-speciﬁc white mat-
ter and demonstrates the tracer uptake localized in cortical greymatter.
Future studies will assess the effect of partial volume correction on the
quantiﬁcation of [18F]ﬂutemetamol data but has been shown to improve
the accuracy in regional SUVR estimates (Thomas et al., 2011).
In a recent report, the use of parametric images of [11C]PiB in visual
assessment was investigated (Zwan et al., 2014) showing a higher
interreader agreement for the assessment of images showing BPND
than for the SUV and SUVR especially among non-AD dementia and
amnestic MCI patients and healthy controls, but to a lesser degree in
AD patients where the interreader agreement was excellent for all
methods. From the results of our study, it can be hypothesized that sim-
ilar effects would be seen for [18F]ﬂutemetamol. In the clinical
setting however, the gain in interreader agreement has to be put in re-
lation to the longer required scanning times.
Conclusions
Parametric imaging allows for quantiﬁcation without any intro-
duced bias due to choice of anatomical regions, thus enabling objective
statistical comparisons of the uptake. For the purpose of quantiﬁcation
of BPND or DVR-1, reference Logan including correction for k2′ shows
the highest correlation with arterial input compartment modeling.
However, the semi-quantitative use of uptake ratios (SUVR) on a
voxel-based level has an almost equally good agreement as the full ki-
neticmodeling, enables shorter scanningwindows and does not require
arterial blood-sampling, which support its use as a simpliﬁed method
for quantitative assessment of tracer uptake.
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